We use cookies to make your experience better. To comply with the new e-Privacy directive, we need to ask for your consent to set the cookies. Learn about our cookie policy.
Sigma-Aldrich Fmoc-(Fmochmb)Gly-Oh Novab
List Price $1,827.00 Your Price $1,827.00
Sigma-Aldrich Fmoc-(Fmochmb)Gly-Oh Novabiochem(R); 1ea; >=95.0% (Acidimetric); >=98% (Tlc); >=98.0% (HPLC) - SIAL (Additional S&H Or Hazmat Fees May Apply)
NETA PART: SIAL-8520640005
MFG.PART: 8520640005
UNSPSC: 41115709
Manufacturer: Sigma-Aldrich


Quality Level
200
Product Line
Novabiochem®
Assay
≥95.0% (acidimetric)
≥98% (TLC)
≥98.0% (HPLC)
Form
powder
Reaction Suitability
reaction type: Fmoc solid-phase peptide synthesis
Manufacturer/Tradename
Novabiochem®
Application(S)
peptide synthesis
Functional Group
Fmoc
Storage Temp.
2-8°C
Related Categories
Amino Acids, Resins & Reagents for Peptide Synthesis
General Description
Hmb protection of amide bonds has been shown to inhibit aggregation of "difficult" peptides by Fmoc SPPS, thereby leading to products of increased purity [1,2,3,4,5,6] . Retention of Hmb groups on the cleaved peptide can greatly improve the solubility of protected peptide fragments [7, 8] and otherwise intractable sequences [9,10,11]. Furthermore, using a Hmb-protected derivative for incorporation of the residue linked to the carboxyl group of Asp or Asn residues has been found to suppress formation of aspartimide and piperidide related by-products [12,13,14] . For a comparison of the efficiency of Hmb and pseudoprolines in preventing aggregation, see [15] .Associated Protocols and Technical Articles
Cleavage and Deprotection Protocols for Fmoc SPPS
Literature references
T. Johnson, et Al. (1993)J. Chem. Soc., Chem. Commun., 369.
C. Hyde, et Al.(1994)Int. J. Peptide Protein Res.,43, 431.
L. C. Packman,et Al. (1994)Pept. Res.,7, 125.
T. Johnson, et Al. (1994)Tetrahedron Lett.,35, 463.
[5] R. g. Simmonds (1996)Int. J. Peptide Protein Res.,47, 36.
[6] T. Johnson, et Al. (1995)Lett. Pept. Sci.,1, 11.
[7] M. Quibell, et Al. (1995)J. Am. Chem. Soc.,117, 11656.
[8] M. Quibell, et Al. (1996)J. Chem. Soc., Perkin Trans.1, 1227.
[9] M. Quibell, et Al. (1994)Tetrahedron Lett.,35, 2237.
[10] M. Quibell, et Al. (1994)J. Org. Chem.,59,1745.
[11] M. Quibell, et Al. (1995)J. Chem. Soc., Perkin Trans. 1, 2019.
[12] M. Quibell, et Al.(1994)J. Chem. Soc., Chem. Commun., 2343.
[13] L. C. Packman (1995)Tetrahedron Lett., 36, 7523.
[14] J. Offer, et Al.(1996)J. Chem. Soc., Perkin Trans. 1, 175.
[15] W. R. Sampson, et Al. (1999)J. Peptide Sci.,5, 403.
Application
- Advances in Fmoc solid‐phase peptide synthesis:An overview of recent advancements in Fmoc-SPPS, including the use of specialized Fmoc-amino acids like Fmoc-(FmocHmb)Gly-OH to improve synthesis efficiency and outcomes (J Offer et Al., 2016).
Linkage
Replaces: 04-12-1135Analysis Note
Colour (visual): white to slight yellow to beigeAppearance of substance (visual): powder
Identity (IR): passes test
Purity (TLC(157A)): ≥ 98 %
Purity (TLC(157B)): ≥ 98 %
Assay (HPLC, area%): ≥ 98.0 % (a/a)
Solubility (1 mmole in 2 mL DMF): clearly soluble
Assay (acidimetric): ≥ 95.0 %
Water (K. F.): ≤ 1.00 %
To see the solvent systems used for TLC of Novabiochem®products please click here.Novabiochem is a registered trademark of Merck KGaA, Darmstadt, Germany
| SKU | SIAL-8520640005 |
|---|---|
| Supplier Part Number | 8520640005 |
| UM | EA |
| UNSPSC | 41115709 |
| Manufacturer | Sigma-Aldrich |
| ProductLine | SIAL |
| Qty | 1 |
| MinOrderQty | 1 |
| Weight | 7.000000 |
| Lead Time | 9 |
| Hazardous | N |
| CAS Number | 148515-84-8 |
| Energy Star | No |
| Green | No |
| Controlled | N |

